Results summary | View all lists in GO:BiolProc | View all genes in A11HA.profile.u50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.72-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
210362_X_AT | PML | G | D | X | P | R | promyelocytic leukemia | ||||||
204271_S_AT | EDNRB | D | S | endothelin receptor type B | |||||||||
214121_X_AT | PDLIM7 | T | D | PDZ and LIM domain 7 (enigma) | |||||||||
208466_AT | RAB3D | T | D | S | RAB3D, member RAS oncogene family | ||||||||
204681_S_AT | RAPGEF5 | D | E | S | Rap guanine nucleotide exchange factor (GEF) 5 | ||||||||
206360_S_AT | SOCS3 | G | P | S | suppressor of cytokine signaling 3 | ||||||||
206714_AT | ALOX15B | G | D | E | arachidonate 15-lipoxygenase, type B | ||||||||
220684_AT | TBX21 | D | X | R | T-box 21 | ||||||||
216265_X_AT | MYH7 | T | D | myosin, heavy chain 7, cardiac muscle, beta | |||||||||
219946_X_AT | MYH14 | myosin, heavy chain 14 | |||||||||||
212362_AT | ATP2A2 | T | D | C | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | ||||||||
207049_AT | SCN8A | T | D | sodium channel, voltage gated, type VIII, alpha subunit |